Hi-Great Group Holding Company

Equities

HIGR

US4283711087

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 01:10:02 19/10/2022 am IST			5-day change	1st Jan Change
0.0178 ^USD	-98.22%		-.--%	-.--%

2023	Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Hi-Great Group Holding Company Reports Earnings Results for the Full Year Ended December 31, 2021

July 13, 2022 at 12:25 am IST

Hi-Great Group Holding Company reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 0.264194 million compared to USD 0.192477 million a year ago. Net income was USD 0.061662 million compared to net loss of USD 0.012782 million a year ago.

Latest news about Hi-Great Group Holding Company

Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Hi-Great Group Holding Company Reports Earnings Results for the First Quarter Ended March 31, 2023	19/23/19	CI
Hi-Great Group Holding Company Reports Earnings Results for the Full Year Ended December 31, 2022	17/23/17	CI
Hi-Great Group Holding Company Auditor Raises 'Going Concern' Doubt	17/23/17	CI
Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	06/22/06	CI
Hi-Great Group Holding Company Reports Earnings Results for the First Quarter Ended March 31, 2022	01/22/01	CI
Hi-Great Group Holding Company Reports Earnings Results for the Full Year Ended December 31, 2021	13/22/13	CI
Hi-Great Group Holding Company Auditor Raises 'Going Concern' Doubt	12/22/12	CI
Hi-Great Group Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	09/22/09	CI
Hi-Great Group Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2021	03/22/03	CI
Hi-Great Group Holding Company Auditor Raises 'Going Concern' Doubt	24/22/24	CI

Chart Hi-Great Group Holding Company

Duration

Period

More charts

Company Profile

Hi-Great Group Holding Company holds a license agreement for New Business Plan with the KRAS gene, which is among the most frequently mutated genes across all cancers, including pancreatic, lung, and colorectal. The Company is engaged in marketing, selling, and distributing SellaCare, Inc's organic longevity health supplement. The Company is in license agreement with SellaCare, Inc. in the areas of longevity and additional health benefits and it also expands into the cosmetic sector as an overall sustainable revenue platform.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
HI-GREAT GROUP HOLDING COMPANY	-.--%	1.78M
MODERNA, INC.	+29.77%	49.18B
IQVIA HOLDINGS INC.	+1.00%	42.11B
LONZA GROUP AG	+50.47%	40.37B
CELLTRION, INC.	-5.26%	28.85B
ICON PUBLIC LIMITED COMPANY	+13.68%	26.09B
ALNYLAM PHARMACEUTICALS, INC.	-22.99%	18.71B
BIO-TECHNE CORPORATION	+8.22%	13.26B
MEDPACE HOLDINGS, INC.	+32.41%	12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.62%	11.99B

Other Biotechnology & Medical Research